4.8 Review

Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2

Vijayakumar Jawalagatti et al.

Summary: The study developed a multivalent mRNA vaccine targeting various proteins and epitopes of SARS-CoV-2. The vaccine induced favorable antibody and cellular immune responses in mice, and showed cross-protection against the delta variant. Oral immunization led to strong mucosal immune response and provided complete protection against viral replication in hamsters.

MOLECULAR THERAPY (2022)

Article Immunology

A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine

Vijayakumar Jawalagatti et al.

Summary: This study presents a simplified mouse model of SARS-CoV-2 that can be developed in any molecular biology lab. The model utilizes adenoviral transduction to generate mice sensitive to SARS-CoV-2 infection. The model can be used to evaluate drugs and vaccines, and has shown the protective effects of an oral mRNA vaccine.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection

Vijayakumar Jawalagatti et al.

Summary: The study aimed to develop a novel vaccine strategy by combining a eukaryotic vector expressing multiple SARS-CoV-2 genes and Salmonella-mediated in vivo DNA delivery, providing new insights into enhancing vaccine efficacy and addressing SARS-CoV-2 variants.

JOURNAL OF ADVANCED RESEARCH (2022)

Review Pharmacology & Pharmacy

Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics

Jacob William Coffey et al.

Summary: Oral vaccination allows for pain-free and self-administered vaccine delivery, inducing both systemic and mucosal immune responses to protect against infection and minimize disease spread. Various challenges in the gastrointestinal tract are being addressed to improve oral vaccine targeting and delivery, with focus on recent advances in oral biologic delivery for future vaccine administration platforms.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)

Review Biochemistry & Molecular Biology

Self-amplifying RNA vaccines for infectious diseases

Kristie Bloom et al.

Summary: Vaccinology is moving towards synthetic RNA platforms, which offer rapid, scalable, and cell-free manufacturing of prophylactic and therapeutic vaccines. Self-amplifying RNAs have shown enhanced antigen expression at lower doses compared to conventional mRNA, potentially improving immunity and becoming important vaccine candidates.

GENE THERAPY (2021)

Editorial Material Chemistry, Medicinal

Addressing the Cold Reality of mRNA Vaccine Stability

Daan J. A. Crommelin et al.

Summary: This commentary discusses the challenges surrounding the stability and formulation of mRNA vaccines, highlighting the need to optimize their formulation for enhanced stability during storage, transport, and administration. Additionally, the mRNA vaccine approach shows evidence of human immunogenicity against multiple viral pathogens and the ability to rapidly adapt to emerging infectious diseases.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Biotechnology & Applied Microbiology

Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs

Zifu Zhong et al.

Summary: Synthetic self-amplifying mRNAs (sa-mRNAs) provide higher and longer-lasting expression compared to conventional mRNA, but also trigger an innate immune response. The use of corticosteroids, especially topical application of clobetasol, can effectively suppress the type I interferon response of sa-mRNA, although it may inhibit antibody formation. Cellulose-based mRNA purification can significantly reduce dsRNA by-products, decreasing the innate immune response and improving sa-mRNA vaccine efficacy.

MOLECULAR THERAPY (2021)

Article Cell Biology

Enhanced SARS-CoV-2 neutralization by dimeric IgA

Zijun Wang et al.

Summary: The IgA response to SARS-CoV-2 was characterized in a cohort of 149 convalescent individuals after COVID-19 diagnosis. IgA responses in plasma generally correlated with IgG responses, and B cells producing IgM, IgG, and IgA were derived from common progenitor cells. Notably, IgA dimers were found to be 15 times more potent than IgA monomers against SARS-CoV-2, suggesting their potential value for protection and vaccine efficacy.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Immunology

Nanomaterial Delivery Systems for mRNA Vaccines

Michael D. Buschmann et al.

Summary: This review highlights the recent success of mRNA vaccines in SARS-CoV-2 clinical trials, emphasizing the crucial role of lipid nanoparticles in the delivery systems and providing an analysis of the determinants of lipid nanoparticles' performance in mRNA vaccines.

VACCINES (2021)

Article Instruments & Instrumentation

Development of vaccine formulations: past, present, and future

Carmine D'Amico et al.

Summary: The ongoing pandemic has brought vaccines into focus again, with traditional vaccines facing challenges in immunogenicity, stability, and storage. Research delves into past, present, and future vaccine formulations, highlighting the use of nanoparticles and microneedle patches as alternative options. The analysis compares injectable solutions, nanovaccines, and microneedles in terms of efficacy, stability, and patient-friendly design.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Resilience and efficiency for the nanotechnology supply chains underpinning COVID-19 vaccine development

Maureen S. Golan et al.

Summary: Nanotechnology has played a key role in advancing the development and commercialization of many SARS-CoV-2 vaccines, but supply chains supporting vaccine manufacturing have shown vulnerability at various stages, requiring strategies for resilience across government, academia, and industry. There is a need for more effective supply chain resilience measures in the absence of quantitative models, consistent definitions, and trade-offs.

CURRENT OPINION IN CHEMICAL ENGINEERING (2021)

News Item Multidisciplinary Sciences

THE TANGLED HISTORY OF MRNA VACCINES

Elie Dolgin

NATURE (2021)

Article Cell Biology

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice

Ahmed O. Hassan et al.

Summary: Intranasal immunization with ChAd-SARS-CoV-2-S in mice induces durable neutralizing and Fc effector antibody responses, providing protection against historical and emerging SARS-CoV-2 strains.

CELL REPORTS (2021)

Review Nanoscience & Nanotechnology

Lipid nanoparticles for mRNA delivery

Xucheng Hou et al.

Summary: Lipid nanoparticle-mRNA formulations have successfully entered clinical use as COVID-19 vaccines, representing a major milestone in mRNA therapeutics. This review discusses the design of lipid nanoparticles for mRNA delivery, emphasizing key points for clinical translation and preclinical studies of lipid nanoparticle-mRNA therapeutics for various diseases.

NATURE REVIEWS MATERIALS (2021)

Review Virology

The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines

Darren Z. L. Mok et al.

VIRUSES-BASEL (2020)

Review Biotechnology & Applied Microbiology

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Piotr S. Kowalski et al.

MOLECULAR THERAPY (2019)

Article Medicine, Research & Experimental

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines

Kimberly J. Hassett et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Review Immunology

Advances in mRNA Vaccines for Infectious Diseases

Cuiling Zhang et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Article Immunology

Adjuvants- and vaccines-induced autoimmunity: animal models

Jiram Torres Ruiz et al.

IMMUNOLOGIC RESEARCH (2017)

Review Biochemistry & Molecular Biology

Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

S. Guan et al.

GENE THERAPY (2017)

Review Immunology

The regulation of gut mucosal IgA B-cell responses: recent developments

N. Y. Lycke et al.

MUCOSAL IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Jesper Pallesen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Biochemistry & Molecular Biology

Modified mRNA Vaccines Protect against Zika Virus Infection

Justin M. Richner et al.

Article Immunology

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Jeffrey M. Jacobson et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)

Article Chemistry, Multidisciplinary

Materials for non-viral intracellular delivery of messenger RNA therapeutics

Kevin J. Kauffman et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Biochemistry & Molecular Biology

Synonymous Codons Direct Cotranslational Folding toward Different Protein Conformations

Florian Buhr et al.

MOLECULAR CELL (2016)

Article Nanoscience & Nanotechnology

Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines

Thomas Demoulins et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)

Review Pharmacology & Pharmacy

mRNA vaccine delivery using lipid nanoparticles

Andreas M. Reichmuth et al.

THERAPEUTIC DELIVERY (2016)

Review Virology

Alphaviruses in Gene Therapy

Kenneth Lundstrom

VIRUSES-BASEL (2015)

Article Immunology

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Lorry G. Rubin et al.

CLINICAL INFECTIOUS DISEASES (2014)

Article Biotechnology & Applied Microbiology

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Luis A. Brito et al.

MOLECULAR THERAPY (2014)

Review Biotechnology & Applied Microbiology

mRNA-based therapeutics - developing a new class of drugs

Ugur Sahin et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Review Biochemistry & Molecular Biology

A critical analysis of codon optimization in human therapeutics

Vincent P. Mauro et al.

TRENDS IN MOLECULAR MEDICINE (2014)

Article Medicine, Research & Experimental

Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo

Kenneth C. McCullough et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2014)

Article Biotechnology & Applied Microbiology

Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines

Charlotte Pollard et al.

MOLECULAR THERAPY (2013)

Review Microbiology

Pre-existing immunity against vaccine vectors - friend or foe?

Manvendra Saxena et al.

MICROBIOLOGY-SGM (2013)

Review Chemistry, Multidisciplinary

Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery

Bert Devriendt et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Review Biotechnology & Applied Microbiology

The polio-eradication programme and issues of the end game

Philip D. Minor

JOURNAL OF GENERAL VIROLOGY (2012)

Article Multidisciplinary Sciences

Dynamics of Salmonella infection of macrophages at the single cell level

Julia R. Gog et al.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2012)

Review Immunology

DNA vaccines: an historical perspective and view to the future

Margaret A. Liu

IMMUNOLOGICAL REVIEWS (2011)

Article Biotechnology & Applied Microbiology

Immunomodulators as adjuvants for vaccines and antimicrobial therapy

Erin F. Nicholls et al.

ANTIMICROBIAL THERAPEUTICS REVIEWS (2010)

Article Biochemistry & Molecular Biology

Microneedles for transdermal drug delivery: a minireview

Jo Vandervoort et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Review Genetics & Heredity

DNA vaccines: ready for prime time?

Michele A. Kutzler et al.

NATURE REVIEWS GENETICS (2008)

Article Biochemistry & Molecular Biology

Biology and application of alphaviruses in gene therapy

K Lundstrom

GENE THERAPY (2005)

Article Multidisciplinary Sciences

Intestinal villous M cells: An antigen entry site in the mucosal epithelium

MH Jang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

mRNA is an endogenous ligand for Toll-like receptor 3

K Karikó et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Review Immunology

The role of dendritic cells during Salmonella infection

MJ Wick

CURRENT OPINION IN IMMUNOLOGY (2002)

Article Multidisciplinary Sciences

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

KA Datsenko et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)